Fisher Paykel Healthcare Stock Price To Earnings To Growth
| FPH Stock | 34.03 1.02 2.91% |
Fisher Paykel Healthcare fundamentals help investors to digest information that contributes to Fisher Paykel's financial success or failures. It also enables traders to predict the movement of Fisher Stock. The fundamental analysis module provides a way to measure Fisher Paykel's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fisher Paykel stock.
Fisher | Price To Earnings To Growth |
Fisher Paykel Healthcare Company Price To Earnings To Growth Analysis
Fisher Paykel's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Fisher Paykel Price To Earnings To Growth | 4.47 X |
Most of Fisher Paykel's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fisher Paykel Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Fisher Paykel Healthcare has a Price To Earnings To Growth of 4.4677 times. This is much higher than that of the Health Care Equipment & Supplies sector and notably lower than that of the Health Care industry. The price to earnings to growth for all Australia stocks is 8.64% higher than that of the company.
Did you try this?
Run Pair Correlation Now
Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments |
| All Next | Launch Module |
Fisher Fundamentals
| Return On Equity | 0.0755 | ||||
| Return On Asset | 0.0985 | ||||
| Profit Margin | 0.08 % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 20.63 B | ||||
| Shares Outstanding | 583.98 M | ||||
| Shares Owned By Insiders | 8.17 % | ||||
| Shares Owned By Institutions | 39.56 % | ||||
| Price To Book | 12.97 X | ||||
| Price To Sales | 11.40 X | ||||
| Revenue | 1.74 B | ||||
| Gross Profit | 938.4 M | ||||
| EBITDA | 444.8 M | ||||
| Net Income | 132.6 M | ||||
| Total Debt | 189.1 M | ||||
| Book Value Per Share | 3.02 X | ||||
| Cash Flow From Operations | 429.6 M | ||||
| Earnings Per Share | 0.20 X | ||||
| Price To Earnings To Growth | 4.47 X | ||||
| Target Price | 35.43 | ||||
| Number Of Employees | 6.98 K | ||||
| Beta | 0.39 | ||||
| Market Capitalization | 19.87 B | ||||
| Total Asset | 2.28 B | ||||
| Retained Earnings | 1.09 B | ||||
| Working Capital | 319.9 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 2.28 B | ||||
| Last Dividend Paid | 0.42 |
About Fisher Paykel Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fisher Paykel Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fisher Paykel using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fisher Paykel Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fisher Stock Analysis
When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.